-
1
-
2Academic Journal
Συγγραφείς: Delva, M. Yu., Nikiforova, O. S.
Πηγή: INTERNATIONAL NEUROLOGICAL JOURNAL; № 2.80 (2016); 126-132
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 2.80 (2016); 126-132
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 2.80 (2016); 126-132Θεματικοί όροι: хронічна мігрень, етіопатогенез, діагностика, профілактика, лікування, treatment, диагностика, лечение, chronic migraine, ethiopathogenesis, diagnostics, prevention, этиопатогенез, 3. Good health, хроническая мигрень, профилактика
Περιγραφή αρχείου: application/pdf
-
3Academic Journal
Συγγραφείς: E. A. Guziy, A. V. Sergeev, G. R. Tabeeva, Е. А. Гузий, А. В. Сергеев, Г. Р. Табеева
Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 16, No 1S (2024): Спецвыпуск: Головная боль; 52-58 ; Неврология, нейропсихиатрия, психосоматика; Vol 16, No 1S (2024): Спецвыпуск: Головная боль; 52-58 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2024-1S
Θεματικοί όροι: прогностическая модель, chronic migraine, alexithymia, catastrophizing, impulsivity, prognostic model, хроническая мигрень, алекситимия, катастрофизация, импульсивность
Περιγραφή αρχείου: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/2384/1737; Chen PK, Wang SJ. Medication Overuse and Medication Overuse Headache: Risk Factors, Comorbidities, Associated Burdens and Nonpharmacologic and Pharmacologic Treatment Approaches. Curr Pain Headache Rep. 2019 Jul 26;23(8):60. doi:10.1007/s11916-019-0796-7; Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012 May;19(5):703-11. doi:10.1111/j.1468-1331.2011.03612.x. Epub 2011 Dec 5.; Табеева ГР, Осипова ВВ, Филатова ЕГ и др. Диагностика и лечение лекарственно-индуцированной головной боли: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2022;14(1):4-13. doi:10.14412/2074-2711-2022-1-4-13; Ashina S, Terwindt GM, Steiner TJ, et al. Medication overuse headache. Nat Rev Dis Primers. 2023 Feb 2;9(1):5. doi:10.1038/s41572-022-00415-0; Shimizu T, Sakai F, Miyake H, et al. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain. 2021 Apr 21;22(1):29. doi:10.1186/s10194-021-01243-5; Vandenbussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018 Jul 13;19(1):50. doi:10.1186/s10194-018-0875-x; Hagen K, Linde M, Steiner TJ, et al. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord- Trondelag Health Studies. Pain. 2012 Jan;153(1):56-61. doi:10.1016/j.pain.2011.08.018. Epub 2011 Oct 22.; He Z, Dong L, Zhang Y, et al. Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China. Eur J Neurol. 2015 Aug;22(8):1228-34. doi:10.1111/ene.12732; Westergaard ML, Glümer C, Hansen EH, Jensen RH. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain. 2014 Oct;155(10):2005-13. doi:10.1016/j.pain.2014.07.002. Epub 2014 Jul 11.; Straube A, Pfaffenrath V, Ladwig KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia. 2010 Feb;30(2):207-13. doi:10.1111/j.1468-2982.2009.01906.x; Ashina M, Terwindt GM, Al-Karagholi MA, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet. 2021 Apr 17;397(10283):1496-504. doi:10.1016/S0140-6736(20)32162-0. Epub 2021 Mar 25.; Recober A, Goadsby PJ. Calcitonin gene-related peptide: A molecular link between obesity and migraine? Drug News Perspect. 2010 Mar;23(2):112-7. doi:10.1358/dnp.2010.23.2.1475909; Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011 Jul;31(9):1015-22. doi:10.1177/0333102411410082. Epub 2011 May 31.; Kebede YT, Mohammed BD, Tamene BA, et al. Medication overuse headache: a review of current evidence and management strategies. Front Pain Res (Lausanne). 2023 Aug 8;4:1194134. doi:10.3389/fpain.2023.1194134; Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008 Sep;48(8):1157-68. doi:10.1111/j.1526-4610.2008.01217.x; Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019 Nov;37(4):631-49. doi:10.1016/j.ncl.2019.06.001. Epub 2019 Aug 27.; Lau CI, Liu MN, Chen WH, et al. Clinical and biobehavioral perspectives: Is medication overuse headache a behavior of dependence? Prog Brain Res. 2020;255:371-402. doi:10.1016/bs.pbr.2020.05.019. Epub 2020 Jun 19.; Florencio LL, de Oliveira AS, Carvalho GF, et al. Association Between Severity of Temporomandibular Disorders and the Frequency of Headache Attacks in Women With Migraine: A Cross-Sectional Study. J Manipulative Physiol Ther. 2017 May;40(4):250-4. doi:10.1016/j.jmpt.2017.02.006. Epub 2017 Apr 6.; Bendtsen L, Munksgaard S, Tassorelli C, et al. COMOESTAS Consortium. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014 May;34(6):426-33. doi:10.1177/0333102413515338. Epub 2013 Dec 9.; Park HK, Chu MK, Oh SY, et al; RELEASE investigators. Interim analysis of the Registry for Load and Management of Medication Overuse Headache (RELEASE): A multicenter, comprehensive medication over- use headache registry. Cephalalgia. 2022 May;42(6):455-65. doi:10.1177/03331024211057184. Epub 2021 Nov 17.; Aaseth K, Grande RB, Kvaerner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30–44-year-old persons. The Akershus study of chronic headache. Cephalalgia. 2008 Jul;28(7):705-13. doi:10.1111/j.1468-2982.2008.01577.x. Epub 2008 May 21.; Cupini LM, De Murtas M, Costa C, et al. Obsessive-compulsive disorder and migraine with medication-overuse headache. Headache. 2009 Jul;49(7):1005-13. doi:10.1111/j.1526-4610.2009.01457.x. Epub 2009 Jun 1.; Fuh JL, Wang SJ, Lu SR, Juang KD. Does medication overuse headache represent a behavior of dependence? Pain. 2005 Dec 15;119(1-3):49-55. doi:10.1016/j.pain.2005.09.034. Epub 2005 Nov 17.; Radat F, Lanteri-Minet M. What is the role of dependence-related behavior in medication- overuse headache? Headache. 2010 Nov;50(10):1597-611. doi:10.1111/j.1526-4610.2010.01755.x. Epub 2010 Aug 27.; Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013 Aug;170(8):834-51. doi:10.1176/appi.ajp.2013.12060782; Radat F, Creac’h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache. 2008 Jul;48(7):1026-36. doi:10.1111/j.1526-4610.2007.00999.x. Epub 2007 Dec 11.; Lake AE 3rd. Medication overuse headache: biobehavioral issues and solutions. Headache. 2006 Oct;46 Suppl 3:S88-97. doi:10.1111/j.1526-4610.2006.00560.x; Robinson TE, Berridge KC. Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46. doi:10.1098/rstb.2008.0093; Cevoli S, Sancisi E, Grimaldi D, et al. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009 Mar;49(3):412-8. doi:10.1111/j.1526-4610.2008.01257.x; First MB. Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. J Nerv Ment Dis. 2013 Sep;201(9):727-9. doi:10.1097/NMD.0b013e3182a2168a; Rosignoli C, Ornello R, Onofri A, et al. Applying a biopsychosocial model to migraine: rationale and clinical implications. J Headache Pain. 2022 Aug 11;23(1):100. doi:10.1186/s10194-022-01471-3; Bigal ME, Sheftell FD, Rapoport AM, et al. MMPI personality profiles in patients with primary chronic daily headache: a case-control study. Neurol Sci. 2003 Oct;24(3):103-10. doi:10.1007/s10072-003-0094-2; Karakurum B, Soylu O, Karatas M, et al. Personality, depression, and anxiety as risk factors for chronic migraine. Int J Neurosci. 2004 Nov;114(11):1391-9. doi:10.1080/00207450490476002; Silberstein SD, Lipton RB, Breslau N. Migraine: association with personality characteristics and psychopathology. Cephalalgia. 1995 Oct;15(5):358-69; discussion 336. doi:10.1046/j.1468-2982.1995.1505358.x; Garramone F, Baiano C, Russo A, et al. Personality profile and depression in migraine: a meta-analysis. Neurol Sci. 2020 Mar;41(3):543-54. doi:10.1007/s10072-019-04174-x. Epub 2019 Dec 12.; Rausa M, Cevoli S, Sancisi E, et al. Personality traits in chronic daily headache patients with and without psychiatric comorbidity: an observational study in a tertiary care headache center. J Headache Pain. 2013 Mar 4;14(1):22. doi:10.1186/1129-2377-14-22; Bottiroli S, Viana M, Sances G, et al. Psychological factors associated with failure of detoxification treatment in chronic headache associated with medication overuse. Cephalalgia. 2016 Dec;36(14):1356-65. doi:10.1177/0333102416631960. Epub 2016 Feb 15.; Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi:10.1177/0333102417738202
-
4Academic Journal
Συγγραφείς: A. V. Sergeev, E. A. Guziy, N. A. Kovalchuk, E. A. Sokolov, G. V. Grigoriev, G. R. Tabeeva, А. В. Сергеев, Е. А. Гузий, Н. А. Ковальчук, Е. А. Соколов, Г. В. Григорьев, Г. Р. Табеева
Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 16, No 1S (2024): Спецвыпуск: Головная боль; 45-51 ; Неврология, нейропсихиатрия, психосоматика; Vol 16, No 1S (2024): Спецвыпуск: Головная боль; 45-51 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2024-1S
Θεματικοί όροι: трансформация мигрени, chronic migraine, detoxification therapy, migraine transformation, хроническая мигрень, «детоксикационная» терапия
Περιγραφή αρχείου: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/2383/1736; Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022 Apr 12;23(1):34. doi:10.1186/s10194-022-01402-2; GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1545-602. doi:10.1016/S0140-6736(16)31678-6. Erratum in: Lancet. 2017 Jan 7;389(10064):e1. doi:10.1016/S0140-6736(16)32606-X; Schwedt TJ, Alam A, Reed ML, et al. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018 May 24;19(1):38. doi:10.1186/s10194-018-0865-z; Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine Progression: A Systematic Review. Headache. 2019 Mar;59(3):306-38. doi:10.1111/head.13459. Epub 2018 Dec 27.; Мербаум ПА, Табеева ГР, Сергеев АВ. Лекарственно-индуцированная головная боль: анализ терапевтических стратегий. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):25-31. doi:10.14412/2074-2711-2020-4-25-31; Сергеев АВ, Мещерина МИ, Табеева ГР. Головная боль, связанная с избыточным приемом анальгетиков: клинико-психологический и нейрофизиологический анализ, особенности периода отмены. Эпилепсия и пароксизмальные состояния. 2011;3(3):21-8.; Chiang CC, Schwedt TJ, Wang SJ, Dodick DW. Treatment of medication-overuse headache: A systematic review. Cephalalgia. 2016 Apr;36(4):371-86. doi:10.1177/0333102415593088. Epub 2015 Jun 29.; Сергеев АВ, Парфенов ВА. Лекарственно-индуцированная головная боль. Практические рекомендации. Медицинский Совет. 2018;(1):26-32. doi:10.21518/2079-701X-2018-1-26-32; Табеева ГР, Осипова ВВ, Филатова ЕГ и др. Диагностика и лечение лекарственно-индуцированной головной боли: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2022;14(1):4-13. doi:10.14412/2074-2711-2022-1-4-13; Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L. Complete detoxification is the most effective treatment of medication-overuse headache: A randomized controlled open-label trial. Cephalalgia. 2018 Feb;38(2):225-36. doi:10.1177/0333102417737779. Epub 2017 Oct 19.; Шагбазян АЭ, Сергеев АВ, Евдокимова ЕМ и др. Роль эмоциональных и поведенческих расстройств в формировании лекарственной зависимости у пациентов с медикаментозно-индуцированной головной болью (обзор). Неврология, нейропсихиатрия, психосоматика. 2016;8(3):76-81. doi:10.14412/2074-2711-2016-3-76-81; Шагбазян АЭ, Гузий ЕА, Табеева ГР. Психологические и поведенческие характеристики пациентов с лекарственно-индуцированной головной болью. Доктор.Ру. 2022;21(4):6-12. doi:10.31550/1727-2378-2022-21-4-6-12; Tassorelli C, Jensen R, Allena M, et al; the COMOESTAS Consortium. A consensus protocol for the management of medicationoveruse headache: Evaluation in a multicentric, multinational study. Cephalalgia. 2014 Aug;34(9):645-55. doi:10.1177/0333102414521508. Epub 2014 Feb 20.; Munksgaard SB, Bendtsen L, Jensen RH. Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design. Cephalalgia. 2012 Aug;32(11):834-44. doi:10.1177/0333102412451363. Epub 2012 Jun 29.
-
5Academic Journal
Συγγραφείς: MOLDOVANU, Ion, BALAN, Marcela-Felicia, ODOBESCU, Stela, ROTARU, Lilia, GROSU, Oxana
Πηγή: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 77 No. 3 (2023): Medical Sciences; 137-141 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 77 Nr. 3 (2023): Ştiinţe medicale; 137-141 ; Вестник Академии Наук Молдовы. Медицина; Том 77 № 3 (2023): Медицина; 137-141 ; 1857-0011
Θεματικοί όροι: эпизодическая мигрень, хроническая мигрень, расстройство личности, пограничное расстройство, migrena episodică, migrena cronică, tulburare de personalitate, Borderline, episodic migraine, chronic migraine, personality disorder
Περιγραφή αρχείου: application/pdf
Relation: https://bulmed.md/bulmed/article/view/3562/3562; https://bulmed.md/bulmed/article/view/3562
-
6Academic Journal
Συγγραφείς: O.Ye. Dubenko
Πηγή: INTERNATIONAL NEUROLOGICAL JOURNAL; Том 16, № 2 (2020); 45-51
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; Том 16, № 2 (2020); 45-51
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; Том 16, № 2 (2020); 45-51Θεματικοί όροι: головная боль при медикаментозной передозировке, хроническая мигрень, нейровизуализационные изменения мозга, отмена медикаментов, головний біль при передозуванні медикаментів, хронічна мігрень, нейровізуалізаційні зміни мозку, відміна медикаментів, medication overuse headache, chronic migraine, brain imaging changes, withdrawal therapy, 3. Good health
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://inj.zaslavsky.com.ua/article/view/200962
-
7Academic Journal
Πηγή: Неврология и нейрохирургия. Восточная Европа. :452-460
Θεματικοί όροι: индекс HIT-6, индекс HALT, HALT index, ботулинический токсин типа А, визуальная аналоговая шкала, профилактическая терапия, HIT-6 index, 3. Good health, botulinum toxin type A, visual analogue scale, 03 medical and health sciences, 0302 clinical medicine, preventive therapy, chronic migraine, хроническая мигрень
-
8Academic Journal
Πηγή: Неврология и нейрохирургия. Восточная Европа. :381-391
Θεματικοί όροι: серотонин, дофамин, risk of development of chronization, хроническая головная боль напряженного типа, 3. Good health, serotonin, 03 medical and health sciences, 0302 clinical medicine, препротахикинин, prepro- tachykinin, chronic migraine, dopamine, риск развития хронизации, хроническая мигрень, chronic tension-type headache
-
9Academic Journal
Συγγραφείς: V. A. Parfenov, В. А. Парфенов
Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 15, No 2 (2023); 4-9 ; Неврология, нейропсихиатрия, психосоматика; Vol 15, No 2 (2023); 4-9 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2023-2
Θεματικοί όροι: хроническая мигрень, selective serotonin reuptake inhibitors, selective serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, stroke, Alzheimer's disease, depression with cognitive impairment, Parkinson's disease, multiple sclerosis, chronic back pain, chronic migraine, селективные ингибиторы обратного захвата серотонина, селективные ингибиторы обратного захвата серотонина и норадреналина, трициклические антидепрессанты, инсульт, болезнь Альцгеймера, депрессия с когнитивными нарушениями, болезнь Паркинсона, рассеянный склероз, хроническая боль в спине
Περιγραφή αρχείου: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/1987/1506; Liu G, Yang X, Xue T, et al. Is Fluoxetine Good for Subacute Stroke? A Meta-Analysis Evidenced From Randomized Controlled Trials. Front Neurol. 2021 Mar 22;12:633781. doi:10.3389/fneur.2021.633781; Романов ДВ, Петелин ДС, Волель БА. Депрессии в неврологической практике. Медицинский совет. 2018;(1):38-45. doi:10.21518/2079-701X-2018-1-38-45.; Мосолов СН. Клиническое применение современных антидепрессантов. Санкт-Петербург: Медицинское информационное агентство; 1995. 568 с.; Elzib H, Pawloski J, Ding Y, Asmaro K. Antidepressant pharmacotherapy and poststroke motor rehabilitation: A review of neurophysiologic mechanisms and clinical relevance. Brain Circ. 2019 Apr-Jun;5(2):62-7. doi:10.4103/bc.bc_3_19. Epub 2019 Jun 27.; Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011 Feb;10(2):123-30. doi:10.1016/S1474-4422(10)70314-8. Epub 2011 Jan 7. Erratum in: Lancet Neurol. 2011 Mar;10(3):205.; Savadi Oskouie D, Sharifipour E, Sadeghi Bazargani H, et al. Efficacy of Citalopram on Acute Ischemic Stroke Outcome: A Randomized Clinical Trial. Neurorehabil Neural Repair. 2017 Jul;31(7):638-47. doi:10.1177/1545968317704902. Epub 2017 Apr 28.; FOCUS Trial Collaboration. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet. 2019 Jan 19;393(10168):265-74. doi:10.1016/S0140-6736(18)32823-X. Epub 2018 Dec 5.; Kalbouneh HM, Toubasi AA, Albustanji FH, et al. Safety and Efficacy of SSRIs in Improving Poststroke Recovery: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2022 Jul 5;11(13):e025868. doi:10.1161/JAHA.122.025868. Epub 2022 Jun 22.; D'Anci KE, Uhl S, Oristaglio J, et al. Treatments for Poststroke Motor Deficits and Mood Disorders: A Systematic Review for the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Stroke Rehabilitation. Ann Intern Med. 2019 Dec 17;171(12):906-15. doi:10.7326/M19-2414. Epub 2019 Nov 19.; Galts CPC, Bettio LEB, Jewett DC, et al. Depression in neurodegenerative diseases: Common mechanisms and current treatment options. Neurosci Biobehav Rev. 2019 Jul;102:56-84. doi:10.1016/j.neubiorev.2019.04.002. Epub 2019 Apr 15.; Weintraub D, Rosenberg PB, Drye LT, et al; DIADS-2 Research Group. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry. 2010 Apr;18(4):332-40. doi:10.1097/JGP.0b013e3181cc0333; Cumbo E, Cumbo S, Torregrossa S, Migliore D. Treatment Effects of Vortioxetine on Cognitive Functions in Mild Alzheimer's Disease Patients with Depressive Symptoms: A 12 Month, Open-Label, Observational Study. J Prev Alzheimers Dis. 2019;6(3):192-7. doi:10.14283/jpad.2019.24; Takemoto M, Ohta Y, Hishikawa N, et al. The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP). J Alzheimers Dis. 2020;76(2):769-72. doi:10.3233/JAD-200247; Elsworthy RJ, Aldred S. Depression in Alzheimer's Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors? J Alzheimers Dis. 2019;69(3):651-61. doi:10.3233/JAD-180780; Perini G, Cotta Ramusino M, Sinforiani E, et al. Cognitive impairment in depression: recent advances and novel treatments. Neuropsychiatr Dis Treat. 2019 May 10;15:1249-58. doi:10.2147/NDT.S199746; Heser K, Bleckwenn M, Wiese B, et al; AgeCoDe Study Group. Late-Life Depressive Symptoms and Lifetime History of Major Depression: Cognitive Deficits are Largely Due to Incipient Dementia rather than Depression. J Alzheimers Dis. 2016 Aug 1;54(1):185-99. doi:10.3233/JAD-160209; Галкин АС, Васильева СН, Симуткин ГГ и др. Изменение когнитивных функций у пациентов с депрессивными расстройствами в процессе терапии селективными ингибиторами обратного захвата серотонина. Современная терапия психических расстройств. 2021;(1):2-7. doi:10.21265/PSYPH.2021.78.55.001; Connors MH, Quinto L, Brodaty H. Longitudinal outcomes of patients with pseudodementia: a systematic review. Psychol Med. 2019 Apr;49(5):727-37. doi:10.1017/S0033291718002829. Epub 2018 Oct 15.; Goodarzi Z, Mrklas KJ, Roberts DJ, et al. Detecting depression in Parkinson disease: A systematic review and meta-analysis. Neurology. 2016 Jul 26;87(4):426-37. doi:10.1212/WNL.0000000000002898. Epub 2016 Jun 29.; Hsu YT, Liao CC, Chang SN, et al. Increased Risk of Depression in Patients with Parkinson Disease: A Nationwide Cohort Study. Am J Geriatr Psychiatry. 2015 Sep;23(9):934-40. doi:10.1016/j.jagp.2014.10.011. Epub 2014 Nov 6.; Devos D, Dujardin K, Poirot I, et al. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord. 2008 Apr 30;23(6):850-7. doi:10.1002/mds.21966; Menza M, Dobkin RD, Marin H, et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology. 2009 Mar 10;72(10):886-92. doi:10.1212/01.wnl.0000336340.89821.b3. Epub 2008 Dec 17.; Richard IH, McDermott MP, Kurlan R, et al; SAD-PD Study Group. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 2012 Apr 17;78(16):1229-36. doi:10.1212/WNL.0b013e3182516244. Epub 2012 Apr 11.; Bomasang-Layno E, Fadlon I, Murray AN, Himelhoch S. Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis. Parkinsonism Relat Disord. 2015 Aug;21(8):833-42; discussion 833. doi:10.1016/j.parkreldis.2015.04.018. Epub 2015 May 16.; Orayj K, Almeleebia T, Vigneshwaran E, et al. Trend of recognizing depression symptoms and antidepressants use in newly diagnosed Parkinson's disease: Population-based study. Brain Behav. 2021 Aug;11(8):e2228. doi:10.1002/brb3.2228. Epub 2021 Jun 14.; Jones CD, Motl R, Sandroff BM. Depression in multiple sclerosis: Is one approach for its management enough? Mult Scler Relat Disord. 2021 Jun;51:102904. doi:10.1016/j.msard.2021.102904. Epub 2021 Mar 18.; Fiest KM, Walker JR, Bernstein CN, et al; CIHR Team Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord. 2016 Jan;5:12-26. doi:10.1016/j.msard.2015.10.004. Epub 2015 Oct 19.; Mohr DC, Boudewyn AC, Goodkin DE, et al. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol. 2001 Dec;69(6):942-9.; Ehde DM, Kraft GH, Chwastiak L, et al. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. Gen Hosp Psychiatry. 2008 Jan-Feb;30(1):40-8. doi:10.1016/j.genhosppsych.2007.08.002; Stubbs B, Koyanagi A, Thompson T, et al. The epidemiology of back pain and its relationship with depression, psychosis, anxiety, sleep disturbances, and stress sensitivity: Data from 43 low- and middle-income countries. Gen Hosp Psychiatry. 2016 Nov-Dec;43:63-70. doi:10.1016/j.genhosppsych.2016.09.008. Epub 2016 Sep 30.; Gerrits MMJG, van Oppen P, van Marwijk HWJ, et al. Pain and the onset of depressive and anxiety disorders. Pain. 2014 Jan;155(1):53-9. doi:10.1016/j.pain.2013.09.005. Epub 2013 Sep 6.; Hung CI, Liu CY, Fu TS. Depression: An important factor associated with disability among patients with chronic low back pain. Int J Psychiatry Med. 2015;49(3):187-98. doi:10.1177/0091217415573937. Epub 2015 Apr 30.; Kolber MR, Ton J, Thomas B, et al. PEER systematic review of randomized controlled trials: Management of chronic low back pain in primary care. Can Fam Physician. 2021 Jan;67(1):e20-e30. doi:10.46747/cfp.6701e20; Urquhart DM, Wluka AE, van Tulder M, et al. Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain: A Randomized Clinical Trial. JAMA Intern Med. 2018 Nov 1;178(11):1474-81. doi:10.1001/jamainternmed.2018.4222. Erratum in: JAMA Intern Med. 2019 Mar 1;179(3):457.; Парфенов ВА, Исайкин АИ. Боли в поясничной области. Москва; 2018.; Amiri S, Behnezhad S, Azad E. Migraine headache and depression in adults: a systematic review and meta-analysis. Neuropsychiatr. 2019 Sep;33(3):131-40. doi:10.1007/s40211-018-0299-5. Epub 2019 Jan 21.; Asif N, Patel A, Vedantam D, et al. Migraine With Comorbid Depression: Pathogenesis, Clinical Implications, and Treatment. Cureus. 2022 Jun 16;14(6):e25998. doi:10.7759/cureus.25998; Rampello L, Alvano A, Chiechio S, et al. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology. 2004;50(4):322-8. doi:10.1159/000080960; MacGregor EA, Frith AA, Hackshaw A. Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study. J Clin Psychopharmacol. 2011 Jun;31(3):392-3. doi:10.1097/JCP.0b013e3182189d70; Curone M, Tullo V, Savino M, et al. Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder. Neurol Sci. 2013 May;34 Suppl 1:S175-7. doi:10.1007/s10072-013-1376-y; Volpe FM. An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache. J Clin Psychiatry. 2008 Sep;69(9):1449-54. doi:10.4088/jcp.v69n0912; Костюкова ЕГ, Мазо ГЭ, Мосолов СН и др. Биполярное аффективное расстройство. Клинические рекомендации. Взрослые. Электронное издание. Минздрав РФ. Москва; 2021. 245 с. Доступно по ссылке: https://cr.minzdrav.gov.ru/recomend/675_1; Мосолов СН, Малин ДИ, Рывкин ПВ, Сычев ДА. Лекарственные взаимодействия препаратов, применяемых в психиатрической практике. Современная терапия психических расстройств. 2019;(S1):2-35. doi:10.21265/PSYPH.2019.50.40828
-
10Academic Journal
Συγγραφείς: G. R. Tabeeva, V. V. Osipova, E. G. Filatova, Yu. E. Azimova, A. V. Amelin, A. R. Artyomenko, Yu. D. Vorobyeva, E. V. Ekusheva, M. I. Koreshkina, E. R. Lebedeva, N. V. Latysheva, M. V. Naprienko, A. V. Sergeev, K. V. Skorobogatykh, V. A. Golovacheva, A. P. Rachin, V. A. Parfenov, Г. Р. Табеева, В. В. Осипова, Е. Г. Филатова, Ю. Э. Азимова, А. В. Амелин, А. Р. Артеменко, Ю. Д. Воробьева, Е. В. Екушева, М. И. Корешкина, Е. Р. Лебедева, Н. В. Латышева, М. В. Наприенко, А. В. Сергеев, К. В. Скоробогатых, В. А. Головачева, А. П. Рачин, В. А. Парфенов
Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 14, No 1 (2022); 4-13 ; Неврология, нейропсихиатрия, психосоматика; Vol 14, No 1 (2022); 4-13 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2022-1
Θεματικοί όροι: нелекарственные методы, evaluation, classification, chronic migraine, chronic tension-type headache, medication-overuse headache treatment, prevention, non-pharmacological methods, диагностика, классификация, хроническая мигрень, хроническая головная боль напряжения, лечение лекарственно-индуцированной головной боли, профилактика
Περιγραφή αρχείου: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/1741/1362; Diener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016 Oct;12(10):575-83. doi:10.1038/nrneurol.2016.124. Epub 2016 Sep 12.; Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medicationoveruse headache. Lancet Neurol. 2010 Apr;9(4):391-401. doi:10.1016/S1474-4422(10)70008-9; Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders ICHD-3, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi:10.1177/0333102417738202; Westergaard ML, Hansen EH, Glümer C, et al. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014;34(6):409-25. doi:10.1177/0333102413512033; Aaseth K, Grande RB, Kvaerner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30–44-yearold persons. The Akershus study of chronic headache. Cephalalgia. 2008 Jul;28(7):705-13. doi:10.1111/j.1468-2982.2008.01577.x. Epub 2008 May 21.; Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011 Jul;31(9):1015-22. doi:10.1177/0333102411410082. Epub 2011 May 31.; Straube A, Pfaffenrath V, Ladwig KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia. 2010 Feb;30(2):207-13. doi:10.1111/j.1468-2982.2009.01906.x; Ayzenberg I, Katsarava Z, Sborowski A, et al; Lifting the Burden. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012 Apr;32(5):373-81. doi:10.1177/0333102412438977; Vandenbussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018 Jul 13;19(1):50. doi:10.1186/s10194-018-0875-x; Dyb G, Holmen T, Zwart J. Analgesic overuse among adolescents with headache: The HeadHunt-Youth Study. Neurology. 2006 Jan 24;66(2):198-201. doi:10.1212/01.wnl.0000193630.03650.19; Lipton RB, Manack A, Ricci JA, et al. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache. 2011 May;51(5):693-706. doi:10.1111/j.1526-4610.2011.01885.x; Wiendels NJ, van der Geest MC, Neven AK, et al. Chronic daily headache in children and adolescents. Headache. 2005 Jun;45(6):678-83. doi:10.1111/j.1526-4610.2005.05137.x; De Rijk P, Resseguier N, Donnet A. Headache characteristics and clinical features of elderly migraine patients. Headache. 2018 Apr;58(4):525-33. doi:10.1111/head.13247. Epub 2017 Dec 13.; Diener HC, Limmroth V. Medication-overused headache: a worldwide problem. Lancet Neurol. 2004 Aug;3(8):475-83. doi:10.1016/S1474-4422(04)00824-5; Colas R, Munoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004 Apr 27;62(8):1338-42. doi:10.1212/01.wnl.0000120545.45443.93; Meskunas CA, Tepper SJ, Rapoport AM, et al. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache. 2006 May;46(5):766-72. doi:10.1111/j.1526-4610.2006.00442.x; Find NL, Terlizzi R, Munksgaard SB, et al; COMOESTAS Consortium. Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study. J Headache Pain. 2015;17:20. doi:10.1186/s10194-016-0612-2. Epub 2016 Mar 8.; Paemeleire K, Bahra A, Evers S, et al. Medication-overuse headache in patients with cluster headache. Neurology. 2006;67(1):109-13 doi:10.1007/s11916-008-0023-4; Robbins MS, Grosberg BM, Napchan U, et al. Clinical and prognostic subforms of new daily-persistent headache. Neurology. 2010 Apr 27;74(17):1358-64. doi:10.1212/WNL.0b013e3181dad5de; Baandrup L, Jensen R. Chronic post-traumatic headache – a clinical analysis in relation to the International Headache Classification. Cephalalgia. 2005 Feb;25(2):132-8. doi:10.1111/j.1468-2982.2004.00818.x; Russell MB, Lundqvist C. Prevention and management of medication overuse headache. Curr Opin Neurol. 2012 Jun;25(3):290-5. doi:10.1097/WCO.0b013e328352c431; Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012 May;19(5):703-11. doi:10.1111/j.1468-1331.2011.03612.x. Epub 2011 Dec 5.; Bendtsen L, Munksgaard S, Tassorelli C, et al; COMOESTAS Consortium. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014 May;34(6):426-33. doi:10.1177/0333102413515338. Epub 2013 Dec 9.; Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al; MOTS Investigators. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache. 2021 Feb;61(2):351-62. doi:10.1111/head.14056. Epub 2021 Jan 12.; Schwedt TJ, Buse DC, Argoff CE, et al. Medication Overuse and Headache Burden Results From the CaMEO Study. Neurol Clin Pract. 2021 Jun;11(3):216-26. doi:10.1212/CPJ.0000000000001037; Tassorelli C, Jensen R, Allena M, et al. The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study. Cephalalgia. 2017 Oct;37(12):1115-25. doi:10.1177/0333102416660549. Epub 2016 Jul 20.; Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol. 2007 Jun;20(3):326-30. doi:10.1097/WCO.0b013e328136c21c; Diener HC, Antonaci F, Braschinsky M, et al. European Academy of Neurology guideline on the management of medication-overuse headache. Eur J Neurol. 2020 Jul;27(7):1102- 16. doi:10.1111/ene.14268. Epub 2020 May 19.; Сергеев АВ, Мещерина МИ, Табеева ГР. Головная боль, связанная с избыточным приемом анальгетиков: клинико-психологический и нейрофизиологический анализ, особенности периода отмены. Эпилепсия и пароксизмальные состояния. 2011;3(3):21-8.; Истомина ОИ, Филатова ЕГ. Абузусная головная боль: социально-демографический и клинический анализ. Врач. 2011;(1):68-71.; Tassorelli C, Jensen R, Allena M, et al. A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia. 2014 Aug;34(9):645-55. doi:10.1177/0333102414521508. Epub 2014 Feb 20.; Kristoffersen ES, Lundqvist C. Medicationoveruse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf. 2014 Apr;5(2):87-99. doi:10.1177/2042098614522683; Osipova V, Jensen R, Tassorelli C. The use of diaries in the management of headache. In: Martelletti P, Steiner TJ, editors. Handbook of Headache (Practical Management). 2011. Vol. 4. P. 197-209. doi:10.1007/978-88-470-1700-9_13; Mitsikostas DD, Ashina M, Craven A, et al & EHF Committee. European Headache Federation consensus on technical investigation for primary headache disorders. J Headache Pain. 2015;17:5. doi:10.1186/s10194-016-0596- y. Epub 2016 Feb 9.; Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1994 Jul;44(7):1353-4. doi:10.1212/wnl.44.7.1353; Осипова ВВ, Скоробогатых КВ, Артеменко АР, Сергеев АВ. Тяжелая лекарственно-индуцированная головная боль с возможными повторными ее статусами у пациента с хронической головной болью напряжения. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):73-8. doi:10.14412/2074-2711-2020-4-73-78.; Филатова ЕГ, Осипова ВВ, Табеева ГР и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):4-14. doi:10.14412/2074-2711- 2020-4-4-14.; Schwedt TJ, Alam A, Reed ML, et al. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018 May 24;19(1):38. doi:10.1186/s10194-018-0865-z; Cevoli S, Sancisi E, Grimaldi D, et al. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009 Mar;49(3):412-8. doi:10.1111/j.1526-4610.2008.01257.x; Bigal ME, Rapoport AM, Sheftell FD, et al. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004 Jun;24(6):483-90. doi:10.1111/j.1468-2982.2004.00691.x; Meng ID, Dodick D, Ossipov MH, Porreca F. Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies. Cephalalgia. 2011 May;31(7):851-60. doi:10.1177/0333102411402367. Epub 2011 Mar 28.; Calabresi P, Cupini L. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci. 2005 Feb;26(2):62-8. doi:10.1016/j.tips.2004.12.008; Srikiatkhachorn A, Anthony M. Serotonin receptor adaptation in patients with analgesicinduced headache. Cephalalgia. 1996 Oct;16(6):419-22. doi:10.1046/j.1468-2982.1996.1606419.x; Kondratieva N, Azimova J, Skorobogatykh K, et al. Biomarkers of migraine: Part 1 – Genetic markers. J Neurol Sci. 2016 Oct 15;369:63-76. doi:10.1016/j.jns.2016.08.008. Epub 2016 Aug 3.; Bongsebandhu-Phubhakdi S, Srikiatkhachorn A. Pathophysiology of medication-overuse headache: implications from animal studies. Curr Pain Headache Rep. 2012 Feb;16(1):110-5. doi:10.1007/s11916-011- 0234-y; Munksgaard S, Ertsey C, Frandsen E, et al. Circulating nociceptin and CGRP in medication-overuse headache. Acta Neurol Scand. 2019 Mar;139(3):269-75. doi:10.1111/ane.13053. Epub 2018 Dec 11.; Riederer F, Schaer M, Gantenbein AR, et al. Cortical Alterations in MedicationOveruse Headache. Headache. 2017 Feb;57(2):255-65. doi:10.1111/head.12993. Epub 2016 Dec 28.; Diener HC, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019 Sep;18(9):891-902. doi:10.1016/S1474-4422(19)30146-2. Epub 2019 Jun 4.; Carlsen LN, Westergaard ML, Bisgaard M, et al. National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia. 2018 Jun;38(7):1316-25. doi:10.1177/0333102417736898. Epub 2017 Oct 10.; Шагбазян АЭ, Ковальчук НА, Табеева ГР. Роль образовательных программ в ведении пациентов с медикаментозно-индуцированной головной болью. Неврология, нейропсихиатрия, психосоматика. 2021;13(3):27-33. doi:10.14412/2074-2711-2021-3-27-33.; Данилов АБ, Шевченко ЕВ. Влияние информационно-образовательной подготовки пациента на клинические, финансово-экономические факторы и удовлетворенность лечением. Неврология, нейропсихиатрия, психосоматика. 2014;(2):29-33. doi:10.14412/2074-2711-2014-2-29-33.; Kristoffersen ES, Straand J, Russell MB, Lundqvist C. Lasting improvement of medication-overuse headache after brief intervention – a long-term follow-up in primary care. Eur J Neurol. 2017 Jul;24(7):883-91. doi:10.1111/ene.13318. Epub 2017 May 23.; Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia. 2006 Oct;26(10):1192-8. doi:10.1111/j.1468-2982.2006.01190.x; Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L. Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial. Cephalalgia 2018;38:225-36. doi:10.1177/0333102417737779; Tepper SJ, Diener HC, Ashina M, et al. Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial. Neurology. 2019 May 14;92(20):e2309- e2320. doi:10.1212/WNL.0000000000007497; De Goffau MJ, Klaver ARE, Willemsen MG, et al. The Effectiveness of Treatments for Patients with Medication Overuse Headache: A Systematic Review and Meta-Analysis. J Pain. 2017 Jun;18(6):615- 27. doi:10.1016/j.jpain.2016.12.005; Сергеев АВ, Парфенов ВА. Лекарственно-индуцированная головная боль. Практические рекомендации. Медицинский совет. 2018;(1):26-32. doi:10.21518/2079-701X2018-1-26-32.; Chiang CC, Schwedt TJ, Wang SJ, Dodick DW. Treatment of medication-overuse headache: a systematic review. Cephalalgia. 2016 Apr;36(4):371-86. doi:10.1177/0333102415593088. Epub 2015 Jun 29.; Rossi P, Di Lorenzo C, Faroni J. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26(9):1097-105. doi:10.1111/j.1468-2982.2006.01175.x; Toom K, Braschinsky M, Obermann M, Katsarava Z. Secondary headache attributed to exposure to or overuse of a substance. Cephalalgia. 2021 Apr;41(4):443-52. doi:10.1177/0333102420942238; Silberstein SD, Lipton RB, Dodick DW, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007 Feb;47(2):170-80. doi:10.1111/j.1526-4610.2006.00684.x; Negro A, Curto M, Lionetto L, Martelletti P. A two years open-label prospective study of OnabotulinumtoxinA. 195 U in medication overuse headache: a real-world experience. J Headache Pain. 2015;17:1. doi:10.1186/s10194-016-0591-3. Epub 2016 Jan 21.; Pazdera L, Ning X, Campos VR, et al. Efficacy of fremanezumab in patients with migraine and documented inadequate response to 3 or 4 migraine preventive medication classes and medication overuse in the international, multicenter, randomized placebo-controlled FOCUS study. Poster, 14th European Headache Federation Congress, 2020. doi:10.1186/s10194-021-01232-8; Raggi A, Giovannetti AM, Leonardi M, et al. Predictors of 12-Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study. Headache. 2017 Jan;57(1):60-70. doi:10.1111/head.12979; Zidverc-Trajkovic JJ, Pekmezovic T, Jovanovic Z, et al. Long-term predictors of remission in patients treated for medication-overuse headache at a specialized headache center: A prospective cohort study. Cephalalgia. 2018 Feb;38(2):265-73. doi:10.1177/0333102416683918
-
11Academic Journal
Συγγραφείς: Табеева, Г. Р., Осипова, В. В., Филатова, Е. Г., Азимова, Ю. Э., Екушева, Е. В.
Θεματικοί όροι: медицина, невропатология, лекарственно-индуцированная головная боль, диагностика, хроническая мигрень, нелекарственные методы
Διαθεσιμότητα: http://dspace.bsu.edu.ru/handle/123456789/52630
-
12Academic Journal
Συγγραφείς: A. A. Kolbin, M. V. Naprienko, A. R. Artemenko, I. A. Vilyum, N. V. Latysheva, M. A. Proskurin, Yu. Ye. Balykina
Πηγή: Качественная клиническая практика, Vol 0, Iss 3, Pp 26-44 (2019)
Θεματικοί όροι: мигрень, хроническая мигрень, профилактика мигрени, пероральные препараты для профилактики мигрени, использование ресурсов здравоохранения, ботокс, исследования стоимости болезни, экономическое влияние болезни, анализ влияния на бюджет, Medical technology, R855-855.5, Pharmacy and materia medica, RS1-441
Περιγραφή αρχείου: electronic resource
Relation: https://www.clinvest.ru/jour/article/view/415; https://doaj.org/toc/2588-0519; https://doaj.org/toc/2618-8473
Σύνδεσμος πρόσβασης: https://doaj.org/article/11be59cdc5a4492daddff819d8b2ed1c
-
13Academic Journal
Πηγή: Неврология, нейропсихиатрия, психосоматика, Vol 0, Iss 0 (2020)
Θεματικοί όροι: мигрень, хроническая мигрень, факторы риска хронификации мигрени, инсомния, цикл сна и бодрствования, хронобиология, биологические ритмы, мелатонин, Neurology. Diseases of the nervous system, RC346-429
Περιγραφή αρχείου: electronic resource
Relation: https://nnp.ima-press.net/nnp/article/view/982; https://doaj.org/toc/2074-2711; https://doaj.org/toc/2310-1342
Σύνδεσμος πρόσβασης: https://doaj.org/article/f4350aede03949888016b9e903c76f55
-
14Academic Journal
Συγγραφείς: Grosu, Oxana, Pleşca, Svetlana, Moldovanu, Ion, Corcea, Galina, Bujor, Oxana, Cojocaru, Ina
Πηγή: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 67 No. 3 (2020): Medical Sciences; 97-102 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 67 Nr. 3 (2020): Ştiinţe medicale; 97-102 ; Вестник Академии Наук Молдовы. Медицина; Том 67 № 3 (2020): Медицина; 97-102 ; 1857-0011
Θεματικοί όροι: мультиморбидность, хроническая мигрень, ревматоидный артрит, хроническая боль, биопсихосоциальная модель, multimorbidity, chronic migraine, rheumatoid arthritis, chronic pain, bio-psycho-social model, multimorbiditate, Migrena cronică, artrita reumatoidă, durere cronică, model bio-psiho-social
Περιγραφή αρχείου: application/pdf
Relation: https://bulmed.md/bulmed/article/view/3253/3253; https://bulmed.md/bulmed/article/view/3253
Διαθεσιμότητα: https://bulmed.md/bulmed/article/view/3253
-
15Academic Journal
Συγγραφείς: Moldovanu, Ion, Mîrzac, Daniela, Odobescu, Stela, Rotaru, Lilia, Grosu, Oxana
Πηγή: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 66 No. 2 (2020): Medical Sciences; 199-205 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 66 Nr. 2 (2020): Ştiinţe medicale; 199-205 ; Вестник Академии Наук Молдовы. Медицина; Том 66 № 2 (2020): Медицина; 199-205 ; 1857-0011
Θεματικοί όροι: хроническая мигрень, эпизодическая мигрень, хронизация боли, аффективное расстройство, вегетативное расстройство, chronic migraine, episodic migraine, chronicity of pain, affective disorder, vegetative disorder, Migrena cronică, migrenă episodică, cronicizarea durerii, tulburare afectivă, tulburare vegetativă
Περιγραφή αρχείου: application/pdf
Relation: https://bulmed.md/bulmed/article/view/3237/3237; https://bulmed.md/bulmed/article/view/3237
Διαθεσιμότητα: https://bulmed.md/bulmed/article/view/3237
-
16Academic Journal
Συγγραφείς: Grosu, O.V., Pleşca, S.M., Плешка, С.М., Moldovanu, I.V., Corcea, G.V., Bujor, O., Cojocaru, I.
Πηγή: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 67 (3) 97-102
Θεματικοί όροι: multimorbiditate, Migrena cronică, artrita reumatoidă, durere cronică, model bio-psiho-social, multimorbidity, chronic migraine, rheumatoid arthritis, chronic pain, bio-psycho-social model, мультиморбидность, хроническая мигрень, ревматоидный артрит, хроническая боль, биопсихосоциальная модель
Περιγραφή αρχείου: application/pdf
Relation: info:eu-repo/grantAgreement/EC/FP7/17150/EU/Utilizarea principiilor medicinii 4P (preventive, predictive, personalizate și participative) in analiza factorilor de risc pentru debutul, perpetuarea și progresarea durerii cronice/20.80009.8007.01; https://ibn.idsi.md/vizualizare_articol/114483; urn:issn:18570011
Διαθεσιμότητα: https://ibn.idsi.md/vizualizare_articol/114483
-
17Academic Journal
Συγγραφείς: Moldovanu, I.V., Mîrzac, D., Odobescu, S.S., Rotaru, L.A., Ротару, Л., Grosu, O.V.
Πηγή: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 66 (2) 199-205
Θεματικοί όροι: Migrena cronică, migrenă episodică, cronicizarea durerii, tulburare afectivă, tulburare vegetativă, chronic migraine, episodic migraine, chronicity of pain, affective disorder, vegetative disorder, хроническая мигрень, эпизодическая мигрень, хронизация боли, аффективное расстройство, вегетативное расстройство
Περιγραφή αρχείου: application/pdf
Relation: info:eu-repo/grantAgreement/EC/FP7/17150/EU/Utilizarea principiilor medicinii 4P (preventive, predictive, personalizate și participative) in analiza factorilor de risc pentru debutul, perpetuarea și progresarea durerii cronice/20.80009.8007.01; https://ibn.idsi.md/vizualizare_articol/114789; urn:issn:18570011
Διαθεσιμότητα: https://ibn.idsi.md/vizualizare_articol/114789
-
18Academic Journal
Πηγή: Неврология, нейропсихиатрия, психосоматика, Vol 0, Iss 0 (2020)
Θεματικοί όροι: мигрень, хроническая мигрень, факторы риска хронификации мигрени, инсомния, цикл сна и бодрствования, хронобиология, биологические ритмы, мелатонин, Neurology. Diseases of the nervous system, RC346-429
Relation: https://nnp.ima-press.net/nnp/article/view/982; https://doaj.org/toc/2074-2711; https://doaj.org/toc/2310-1342; https://doaj.org/article/f4350aede03949888016b9e903c76f55
Διαθεσιμότητα: https://doaj.org/article/f4350aede03949888016b9e903c76f55
-
19Report
Θεματικοί όροι: лечение мигрени, cervicalgia, головная боль, Хроническая мигрень, физиотерапия, 3. Good health, migraine treatment, дифференциальная диагностика, quality of life, electrotherapy, differential diagnosis, электротерапия, качество жизни, headache, цервикалгия, physiotherapy, Chronic migraine
-
20